{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:21:45Z","timestamp":1778595705293,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23fk0410038h003"],"award-info":[{"award-number":["23fk0410038h003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jiac.2024.02.017","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T16:26:58Z","timestamp":1708446418000},"page":"1061-1064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Local radiotherapy for chemotherapy-refractory Kaposi's sarcoma in an HIV-infected patient: A case report and literature review"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8791-1513","authenticated-orcid":false,"given":"Yutaro","family":"Yoshitomi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-7966","authenticated-orcid":false,"given":"Akira","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetsugu","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takato","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5520-2780","authenticated-orcid":false,"given":"Naokatsu","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1697-7364","authenticated-orcid":false,"given":"Junko","family":"Tanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuji","family":"Teruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Gatanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3190-8439","authenticated-orcid":false,"given":"Koji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jiac.2024.02.017_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/QAD.0000000000000071","article-title":"Malignancies in HIV\/AIDS: from epidemiology to therapeutic challenges","volume":"28","author":"Rubinstein","year":"2014","journal-title":"AIDS"},{"issue":"5336","key":"10.1016\/j.jiac.2024.02.017_bib2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.278.5336.290","article-title":"Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines","volume":"278","author":"Boshoff","year":"1997","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.jiac.2024.02.017_bib3","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1200\/JCO.2005.05.4072","article-title":"Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement","volume":"24","author":"Grabar","year":"2006","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jiac.2024.02.017_bib4","first-page":"2153","article-title":"Radiation therapy in the treatment of HIV-related Kaposi's sarcoma","volume":"33","author":"Donato","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jiac.2024.02.017_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(07)70036-0","article-title":"Management of AIDS-related Kaposi's sarcoma","volume":"8","author":"Lorenzo","year":"2007","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jiac.2024.02.017_bib6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.2013.51.6757","article-title":"Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma","volume":"32","author":"Bower","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jiac.2024.02.017_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2019.e00571","article-title":"Kaposi sarcoma with musculoskeletal manifestations in a well-controlled HIV patient","volume":"17","author":"Verdecia","year":"2019","journal-title":"IDCases"},{"issue":"8","key":"10.1016\/j.jiac.2024.02.017_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/QAD.0b013e3282ff6275","article-title":"Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response","volume":"22","author":"Nguyen","year":"2008","journal-title":"AIDS"},{"issue":"9521","key":"10.1016\/j.jiac.2024.02.017_bib9","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)68649-2","article-title":"A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy","volume":"367","author":"Stebbing","year":"2006","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jiac.2024.02.017_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jmii.2015.10.009","article-title":"Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: a nested case-control study in Kenya","volume":"50","author":"Lupia","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"10.1016\/j.jiac.2024.02.017_bib11","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/cam4.312","article-title":"Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men","volume":"3","author":"Luu","year":"2014","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.jiac.2024.02.017_bib12","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.1998.16.7.2445","article-title":"Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial","volume":"16","author":"Northfelt","year":"1998","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jiac.2024.02.017_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1634\/theoncologist.12-1-114","article-title":"A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma","volume":"12","author":"Cooley","year":"2007","journal-title":"Oncol"},{"issue":"6","key":"10.1016\/j.jiac.2024.02.017_bib14","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.1999.17.6.1876","article-title":"Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma","volume":"17","author":"Bresnahan","year":"1999","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jiac.2024.02.017_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cncr.10634","article-title":"Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma","volume":"95","author":"Tulpule","year":"2002","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.jiac.2024.02.017_bib16","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1200\/JCO.2000.18.7.1550","article-title":"Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study","volume":"18","author":"Nasti","year":"2000","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.jiac.2024.02.017_bib17","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1200\/JCO.2002.12.038","article-title":"Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study","volume":"20","author":"Evans","year":"2002","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jiac.2024.02.017_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3857\/roj.2020.00885","article-title":"Palliative treatment of Kaposi sarcoma with radiotherapy: a single center experience","volume":"39","author":"Inan","year":"2021","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.jiac.2024.02.017_bib19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ijc.20606","article-title":"Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial","volume":"113","author":"Plweny","year":"2005","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.jiac.2024.02.017_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13256-016-1101-6","article-title":"Classic Kaposi's sarcoma -complete response to radiation therapy: a case report","volume":"10","author":"Ram\u00edrez","year":"2016","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jiac.2024.02.017_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/jcrt.JCRT_115_18","article-title":"Electron beam radiotherapy for Kaposi's sarcoma of the toe and web","volume":"16","author":"Lee","year":"2020","journal-title":"J Cancer Res Therapeut"},{"issue":"2","key":"10.1016\/j.jiac.2024.02.017_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.6004\/jnccn.2019.0008","article-title":"AIDS-related Kaposi sarcoma, version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Reid","year":"2019","journal-title":"J Natl Compr Cancer Netw"},{"issue":"2","key":"10.1016\/j.jiac.2024.02.017_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2008.03.009","article-title":"Hypofractionated radiation therapy in the treatment of epidemic Kaposi sarcoma--a prospective randomized trial","volume":"88","author":"Singh","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jiac.2024.02.017_bib24","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3390\/cancers14081915","article-title":"The role of radiotherapy in treating Kaposi's sarcoma in HIV infected patients","volume":"14","author":"Qu\u00e9ro","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.jiac.2024.02.017_bib25","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI119380","article-title":"Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy","volume":"99","author":"Kedes","year":"1997","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.jiac.2024.02.017_bib26","first-page":"1101","article-title":"Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal free\/chelsea and westminster hospitals collaborative group","volume":"10","author":"Mocroft","year":"1996","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.jiac.2024.02.017_bib27","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/infdis\/173.6.1477","article-title":"Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study","volume":"173","author":"Glesby","year":"1996","journal-title":"J Infect Dis"},{"issue":"26","key":"10.1016\/j.jiac.2024.02.017_bib28","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1182\/blood-2010-11-317610","article-title":"High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy","volume":"117","author":"Uldrick","year":"2011","journal-title":"Blood"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:55:42Z","timestamp":1778594142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1341321X24000527"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.02.017","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local radiotherapy for chemotherapy-refractory Kaposi's sarcoma in an HIV-infected patient: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}